首页|黑逍遥散通过MKP-1/JNK通路改善阿尔茨海默病大鼠的研究

黑逍遥散通过MKP-1/JNK通路改善阿尔茨海默病大鼠的研究

扫码查看
目的 探究黑逍遥散调控丝裂原活化蛋白激酶磷酸酶-1(MKP-1)/c-Jun氨基末端激酶(JNK)信号通路干预阿尔茨海默病(AD)大鼠海马Tau蛋白表达、抑制神经炎症的作用,及其作用机制.方法 将SPF级Wistar雄性大鼠随机分为空白组、假手术组、模型组、对照组和低、中、高剂量实验组,每组10只.除空白组和假手术组外,其余5组大鼠双侧海马区注射β-淀粉样蛋白1-42(Aβ1-42)溶液复制AD大鼠模型,假手术组相同方法注射等量0.9%NaCl.将造模成功的大鼠随机分为模型组、对照组(0.5 mg·kg-1盐酸多奈哌齐)和低、中、高剂量实验组(3.82、7.65、15.30 g·kg-1黑逍遥散汤剂).空白组、假手术组和模型组均灌胃给予等体积的0.9%NaCl.7组大鼠每天灌胃1次,连续灌胃给药42 d.用Morris水迷宫检测大鼠学习记忆能力,用酶联免疫吸附试验法检测海马组织中肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平,用蛋白质印迹法检测MKP-1、磷酸化JNK(p-JNK)、磷酸化Tau(p-Tau)蛋白的表达水平.结果 中、高剂量实验组和对照组、模型组、假手术组、空白组第5天逃避潜伏期分别为(8.28±7.67)、(7.89±4.18)、(7.86±2.68)、(16.55±4.16)、(6.46±3.30)和(3.60±1.53)s,TNF-α 水平分别为(406.56±28.44)、(404.17±22.84)、(402.28±28.36)、(665.89±61.15)、(226.44±34.84)和(218.50±30.16)pg·mL-1,IL-6 水平分别为(136.54±7.04)、(121.67±5.19)、(119.15±5.87)、(166.27±8.91)、(88.75±5.28)和(79.58±7.53)ng·L-1,MKP-1 蛋白相对表达水平分别为 2.31±0.34、2.59±0.38、2.58±0.37、1.23±0.25、2.64±0.19和 2.84±0.18,p-JNK 蛋 白相对表达水平分别为 3.46±0.35、3.45±0.31、3.20±0.23、4.48±0.30、2.87±0.51 和 2.30±0.26,p-Tau 蛋白相对表达水平分别为 3.46±0.33、3.24±0.48、3.09±0.31、4.85±1.06、2.69±0.34 和2.40±0.55.中、高剂量实验组的上述指标与模型组比较,在统计学上差异均有统计学意义(P<0.05,P<0.01).结论 黑逍遥散可显著改善AD大鼠的学习记忆能力,其作用机制可能与调控MKP-1与JNK蛋白,从而抑制Tau蛋白磷酸化水平、减轻神经炎症有关.
Research of Heixiaoyao powder improve the Alzheimer's disease rats through the MKP-1/JNK pathway
Objective To investigate the effect and mechanism of Heixiaoyao powder in regulating mitogen-activated protein kinase phosphatase-1(MKP-1)/c-Jun N-terminal kinase(JNK)signaling pathway on the level of Tau protein and neuroinflammation in the hippocampus of Alzheimer's disease(AD)rats.Methods Male Wistar rats with SPF grade were randomly divided into blank,sham-operation,model,control and experimental-L,-M,-H groups with 10 rats per group.In addition to the blank and sham-operation groups,the other 5 groups of rats were injected with β-amyloid 1-42(Aβ1-42)solution in bilateral hippocampus to replicate AD rat model,and the sham-operation group was injected with the same amount of 0.9%NaCl in the same way.Animals successfully replicated in the model were randomly divided into model group,control group(0.5 mg·kg-1 donepezil hydrochloride)and experimental-L,-M,-H groups(3.82,7.65,15.30 g·kg-1 Heixiaoyao powder decoction).The blank,sham-operation and model groups were given equal volume of 0.9%NaCl by gavage.The drug was given by gavage once a day for 42 days.Morris water maze was used to detect the learning and memory ability of rats.The levels of tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)in hippocampus were detected by enzyme-linked immunosorbent assay.Western blot was used to detect the expression of MKP-1,phospho JNK(p-JNK)and phospho Tau(p-Tau)proteins.Results The escape latency on day 5 of the experimental-M,-H groups,control group,model group,sham-operation group and blank group were(8.28±7.67),(7.89±4.18),(7.86±2.68),(16.55±4.16),(6.46±3.30)and(3.60±1.53)s;the levels of TNF-α in the above groups were(406.56±28.44),(404.17±22.84),(402.28±28.36),(665.89±61.15),(226.44±34.84)and(218.50±30.16)pg·mL-1;IL-6 levels were(136.54±7.04),(121.67±5.19),(119.15±5.87),(166.27±8.91),(88.75±5.28)and(79.58±7.53)ng·L-1;the relative expression levels of MKP-1 protein were 2.31±0.34,2.59±0.38,2.58±0.37,1.23±0.25,2.64±0.19 and 2.84±0.18;the relative expression levels of p-JNK protein were 3.46±0.35,3.45±0.31,3.20±0.23,4.48±0.30,2.87±0.51 and 2.30±0.26;the relative expression levels of p-Tau protein were 3.46±0.33,3.24±0.48,3.09±0.31,4.85±1.06,2.69±0.34 and 2.40±0.55,respectively.Compared with the model group and the normal group,compared with the experimental group and the model group,the differences of above indexes were statistically significant(P<0.05,P<0.01).Conclusion Heixiaoyao powder can improve the learning and memory ability of AD rats,and its mechanism may be related to the regulation of MKP-1 and JNK proteins,thus inhibiting the phosphorylation level of Tau protein and alleviating neuroinflammation.

Heixiaoyao powderAlzheimer's diseaseMAP kinase phosphatase-1/c-Jun N-terminal kinase pathwayTau proteinneuroinflammation

王虎平、孟志鹏、胡韵韵、吕育洁、杨娇、陈怡琴

展开 >

甘肃中医药大学 基础医学院,甘肃兰州 730000

甘肃省中医方药挖掘与创新转化重点实验室、甘肃省中药新产品创制工程实验室,甘肃兰州 730000

黑逍遥散 阿尔茨海默病 丝裂原活化蛋白激酶磷酸酶-1/c-Jun氨基末端激酶信号通路 Tau蛋白 神经炎症

国家自然科学基金资助项目国家自然科学基金资助项目兰州市科技计划基金资助项目第五批全国中医临床优秀人才研修基金资助项目首批陇原青年英才基金资助项目

82160862819608282020-ZD-53国中医药人教函[2022]239号[2022]25号

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(17)